Estrogens are potentially the only steroids with an antioxidant role in pregnancy: In vitro evidence

Acta Obstetricia et Gynecologica Scandinavica

Volumn 85, Issue 9, 2006, Pages 1090-1093

  Reyes, Miguel R ^a,b   Sifuentes Alvarez, Antonio ^a   Lazalde, Brissia ^a  

^a UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^b NONE   (Mexico)

Author keywords

Antioxidants; Estriol; Estrogens; Oxidative stress; Pre eclampsia

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ANTIOXIDANT; ESTRADIOL; ESTRIOL; ESTROGEN; LINOLEIC ACID; PRASTERONE SULFATE; PROGESTERONE; REACTIVE OXYGEN METABOLITE; STEROID; STEROID HORMONE; TESTOSTERONE;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; ELECTRON TRANSPORT; EVIDENCE BASED MEDICINE; HORMONE ACTION; IN VITRO STUDY; OXIDATIVE STRESS; PATHOGENESIS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL;

ADULT; ANTIOXIDANTS; BIPHENYL COMPOUNDS; DEHYDROEPIANDROSTERONE SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTRIOL; ESTROGENS; FEMALE; HUMANS; HYDRAZINES; LINOLEIC ACID; LIPID PEROXIDATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PREGNANCY; PROGESTERONE; REACTIVE OXYGEN SPECIES; TESTOSTERONE;

EID: 33747757721     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340500453685     Document Type: Article

References (20)

1. Myatt L, Cui X. Oxidative stress in the placenta. Histochem Cell Biol. 2004;122:1369-82.
2. Raijmakers MTM, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension. 2004;44:374-80.
3. Moretti M, Phillips M, Abouzeid A, Cataneo RN, Greenberg J. Increased breath markers of oxidative stress in normal pregnancy and in preeclampsia. Am J Obstet Gynecol. 2003;/190:1184-90.
4. Bowen RS, Moodley J, Dutton MF, Theron AJ. Oxidative stress in pre-eclampsia. Acta Obstet Gynecol Scand. 2001;80: 719-25.
5. Roberts JM, Hubel CA. Oxidative stress in preeclampsia. Am J Obstet Gynecol. 2004;190:1177-8.
6. Vanderlelie J, Venardos K, Clifton VL, Gude NM, Clarke FM, Perkins AV. Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae. Placenta. 2005;26:53-8.
7. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science. 2005;308:1592-4.
8. Reyes Romero MA. The physiological role of estriol during human fetal development is to act as antioxidant at lipophilic milieus of the central nervous system. Med Hypotheses. 2001; 56:107-9.
9. Ruiz-Larrea MB, Martin C, Martinez R, Navarro R, Lacort M, Miller NJ. Antioxidant activities of estrogens against aqueous and lipophilic radicals; differences between phenol and catechol estrogens. Chem Phys Lipids. 2000;105: 179-88.
10. Cunnane SC, Crawford MA. Survival of the fattest: fat babies were the key to evolution of the large human brain. Comp Biochem Physiol A Mol Integr Physiol. 2003;136:17-26.
11. Crawford MA. Cerebral evolution. Nutr Health. 2002;16: 29-34.
12. Mueller A, Koebnick C, Binder H, Hoffmann I, Schild RL, Beckmann MW, et al. Placental defence is considered sufficient to control lipid peroxidation in pregnancy. Med Hypotheses. 2005;64:553-7.
13. Mihaljevic B, Katusin-Razem B, Razem D. The reevaluation of the ferric thiocyanate assay for lipid hydroperoxides with special considerations of the mechanistic aspects of the response. Free Radic Biol Med. 1996;21:53-63.
14. Cotelle N, Bernier JL, Catteau JP, Pomery J, Wallet JC, Gaydou EM. Antioxidant properties of hydroxyflavones. Free Radic Biol Med. 1996;20:35-43.
15. Sanchez-Moreno C, Larrauri JA, Saura-Calixto F. A procedure to measure the antiradical efficiency of polyphenols. J Sci Food Agric. 1998;76:270-6.
16. Raijmakers MT, van Tits BJ, Hak-Lemmers HL, Roes EM, Steegers EA, Peters WH. Low plasma levels of oxidized low density lipoprotein in preeclampsia. Acta Obstet Gynecol Scand. 2004;83:1173-7.
17. Behl C. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci. 2002;3:433-42.
18. Bednarek-Tupikowska G, Tupikowski K, Bidzinska B, Bohdanowicz-Pawlak A, Antonowicz-Juchniewicz J, Kosowska B, et al. Serum lipid peroxides and total antioxidant status in postmenopausal women on hormone replacement therapy. Gynecol Endocrinol. 2004;19:57-63.
19. Troisi R, Potischman R, Roberts JM, Harger G, Markovic N, Cole B, et al. Correlation of serum hormone concentrations in maternal and umbilical cord samples. Cancer Epidemiol Biomarkers Prev. 2003;12:452-6.
20. Huang D, Ou B, Prior RL. The chemistry behind antioxidant capacity assays. J Agric Food Chem. 2005;53:1841-56.